Lanean...
Natalizumab treatment is associated with peripheral sequestration of proinflammatory T cells
BACKGROUND: Natalizumab is an antibody directed against integrin α4 that reduces disease activity in patients with multiple sclerosis (MS) by blocking migration of T and B cells into the CNS. The goal of this study was to characterize the effects of natalizumab treatment on cytokine production and e...
Gorde:
| Egile Nagusiak: | , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
American Academy of Neurology
2009
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2690969/ https://ncbi.nlm.nih.gov/pubmed/19487650 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0b013e3181a8266f |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|